WO2016081468A2 - Implantable electro-medical device programmable for improved operational life - Google Patents

Implantable electro-medical device programmable for improved operational life Download PDF

Info

Publication number
WO2016081468A2
WO2016081468A2 PCT/US2015/061108 US2015061108W WO2016081468A2 WO 2016081468 A2 WO2016081468 A2 WO 2016081468A2 US 2015061108 W US2015061108 W US 2015061108W WO 2016081468 A2 WO2016081468 A2 WO 2016081468A2
Authority
WO
WIPO (PCT)
Prior art keywords
function
power source
current
battery
parameters
Prior art date
Application number
PCT/US2015/061108
Other languages
French (fr)
Other versions
WO2016081468A3 (en
Inventor
Bevil Hogg
Virender K. Sharma
Shai Policker
Paul V. Goode
Kaila Raby
Original Assignee
Endostim, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endostim, Inc. filed Critical Endostim, Inc.
Priority to EP15861744.9A priority Critical patent/EP3220999A2/en
Publication of WO2016081468A2 publication Critical patent/WO2016081468A2/en
Publication of WO2016081468A3 publication Critical patent/WO2016081468A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/378—Electrical supply
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R31/00—Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
    • G01R31/36—Arrangements for testing, measuring or monitoring the electrical condition of accumulators or electric batteries, e.g. capacity or state of charge [SoC]
    • G01R31/382—Arrangements for monitoring battery or accumulator variables, e.g. SoC
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F1/00—Details not covered by groups G06F3/00 - G06F13/00 and G06F21/00
    • G06F1/26—Power supply means, e.g. regulation thereof
    • G06F1/32—Means for saving power
    • G06F1/3203—Power management, i.e. event-based initiation of a power-saving mode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36125—Details of circuitry or electric components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/37—Monitoring; Protecting
    • A61N1/3706—Pacemaker parameters
    • A61N1/3708—Pacemaker parameters for power depletion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/378—Electrical supply
    • A61N1/3787—Electrical supply from an external energy source

Definitions

  • This invention relates generally to an electro-medical device for electrical stimulation of one or more anatomical target sites to treat a plurality of biological conditions. More particularly, this invention relates to an electro -medical device that is programmable for improved operational life with reference to a plurality of desired treatment stimulations or protocols.
  • Electrical stimulation has been suggested for use in the treatment of biological conditions of patient's, such as, obesity and GERD.
  • the treatment typically involves placing stimulator electrodes, of an electro-medical device, at or near an anatomical site in the patient by endoscopic, surgical or radiological procedures.
  • the operational life of such electro-medical devices is contingent upon the service life of the battery or energy source powering the device.
  • the service life of the energy source is in turn affected by the electrical stimulation regimen and therefore a plurality of parameters governing the regimen.
  • the present specification discloses a device for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said device comprising: a pulse generator providing electrical stimulation to said one or more anatomical target sites, wherein said electrical stimulation comprises a stimulation current; a power source for powering said pulse generator; at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; and, a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
  • IBAT [(eff TH ⁇ I TH ⁇ ⁇ PRF ⁇ PW) + I S0H ] ⁇ DC TH + I SLP ⁇ (1 - DC TH ) + I w
  • effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency;
  • the power source is a battery.
  • the battery may be rechargeable or non- rechargeable.
  • the operational life parameters of the battery may comprise battery capacity, usable efficiency of battery due to end of life efficiency, and battery current.
  • the power source is a capacitor.
  • the therapy protocol parameters, for an electrical stimulation pulse train may comprise: number of pulses, shape of pulses, interval between pulse train repetitions, duration of a pulse, timing and amplitude of pulses, amperage to be provided to said one or more anatomical target sites, potential to be provided to said one or more anatomical target sites, and duty cycles.
  • the device further comprises at least one sensor for monitoring at least one physiological parameter of said patient.
  • the microprocessor may modify said therapy protocol parameters based upon physiological information sensed by said at least one sensor.
  • the present specification also discloses a device for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said device comprising: a pulse generator providing electrical stimulation to said one or more anatomical target sites; a power source for powering said pulse generator; at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
  • IBAT [ ⁇ effrn ⁇ ITH ⁇ ⁇ ⁇ £iL ⁇ PRF ⁇ PW) + I S0H ] ⁇ DC TH + I SLP ⁇ (1 - DC TH ) + I ;
  • At least one sensor connected to said microprocessor for sensing at least one physiological parameter of said patient; wherein effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency; wherein PW is a function of a pulse width; wherein DCTH is a function of a duty cycle; wherein ISLP is
  • the power source is a battery.
  • the battery may be rechargeable or non- rechargeable.
  • the operational life parameters of the battery may comprise battery capacity, usable efficiency of battery due to end of life efficiency, and battery current.
  • the power source is a capacitor.
  • the therapy protocol parameters, for an electrical stimulation pulse train may comprise: number of pulses, shape of pulses, interval between pulse train repetitions, duration of a pulse, timing and amplitude of pulses, amperage to be provided to said one or more anatomical target sites, potential to be provided to said one or more anatomical target sites, and duty cycles.
  • the present specification also discloses a system for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said system comprising: a pulse generator providing electrical stimulation to said one or more anatomical target sites; a power source for powering said pulse generator; at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; and, a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
  • the power source is a battery.
  • the battery may be rechargeable or non- rechargeable.
  • the power source is a capacitor.
  • the system further comprises at least one sensor for monitoring at least one physiological parameter of said patient.
  • the microprocessor may modify said therapy protocol parameters based upon physiological information sensed by said at least one sensor.
  • Figure 1 is a block diagram illustration of an electro-medical device in accordance with an embodiment
  • Figure 2 shows exemplary therapy protocol parameters
  • Figure 3 is a flow chart illustrating the steps involved in one embodiment of setting a maximum power source capacity and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
  • Figure 4 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum power source capacity and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification;
  • Figure 5 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum amount of current required to run the device, and not including the stimulation current, and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
  • Figure 6 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum useable efficiency of power source and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
  • Figure 7 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of current existing the device from an output terminal and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
  • Figure 8 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of voltage at an output terminal of the device and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification;
  • Figure 9 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of an overhead output voltage and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
  • Figure 10 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of battery or power source output voltage and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
  • Figure 11 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of sleep current and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification;
  • Figure 12 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of average telemetry current and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification.
  • the present invention is directed towards a plurality of operational or therapy protocol parameters with battery parameters for improved or enhanced operational life of a programmable implantable electro-medical device for the treatment of a plurality of biological conditions.
  • the electro-medical device including macrostimulators or microstimulators, typically employs stimulator electrodes which can be implanted with minimal invasiveness at or near a treatment or stimulation site.
  • the electro-medical device can be used to treat a plurality of biological conditions and achieve a plurality of different therapeutic objectives: treatment of GERD (gastroesophageal reflux disease); treatment of diurnal GERD; treatment of nocturnal GERD; reducing the frequency of transient lower esophageal relaxation (tLESR) events; reducing acid exposure during tLESR events; normalizing a patient's LES (lower esophageal sphincter) function; treatment of hypotensive LES; increasing resting or baseline LES pressure; treating a patient to normalize esophageal pH; treating a patient to normalize esophageal pH when in the supine position; treating a patient to prevent damage to the patient's lower esophageal sphincter caused by acid reflux; treatment of supine position induced GERD; treatment of activity-induced GERD; prevention of supine position induced GERD; prevention of activity-induced GERD;
  • the electro-medical device may be implanted within a plurality of anatomical target sites or regions to achieve one or more of the therapeutic objectives described above.
  • Treatment/target sites, or implantation sites include: the lower esophageal sphincter; proximate the LES or in the vicinity of the LES, wherein proximate or in the vicinity of the LES is defined as +/- 3 cm from the LES; the esophageal body; the upper esophageal sphincter (UES); within, proximate to, or in the vicinity of the gastro-esophageal junction; the esophagus, including esophageal body, LES, and UES; proximate the esophagus or in the vicinity of the esophagus, wherein proximate or in the vicinity of the esophagus is defined as +/- 3 cm from the esophagus; at or within the stomach; in direct contact with or +/- 3 cm
  • the electro-medical device may be a conventional pulse generator, a miniature pulse generator, or a microstimulator.
  • any electro-medical device including a macrostimulator or microstimulator, can be programmed to achieve improved or enhanced operational life of the device while implementing a plurality of desired operational or therapy protocols.
  • an electro-medical device such as a macrostimulator or microstimulator, having a plurality of electrodes, or at least one electrode, including, but not limited to, unipolar or bipolar electrodes, an energy source, such as a battery, and a microprocessor which stores a plurality of programmatic instructions wherein the instructions, when executed by the device, execute the stimulation therapies while achieving optimized and/or improved operational life of the device.
  • Figure 1 shows an embodiment of an electro-medical device 100 wherein a plurality of stimulator electrodes 105 is provided for placement at or near a treatment or stimulation site.
  • a pulse generator 110 is provided for stimulation of the stimulator electrodes 105 and corresponding portion of the treatment or stimulation site.
  • the pulse generator 110 is connected to a power source 115 for supplying a source of power.
  • the pulse generator 110 is further connected to the stimulator electrodes 105 by wires 106 for applying electrical stimulus to the electrodes 105.
  • the stimulator electrodes 105 may be coupled to the pulse generator 110 in a wireless fashion using an RF link, an ultrasonic link, a thermal link, a magnetic link, an electromagnetic link or an optical link.
  • the power source 115 can be either a direct current source or an alternating current source.
  • the number of stimulator electrodes 105 is determined by a number of factors, including the size of the electrodes, their power and the size of the desired placement area.
  • the pulse generator 110 is controlled by a microprocessor 120 for applying the electrical stimulus for periods of variable duration and variable power/frequency, so as to produce a plurality of treatment stimulations/therapies.
  • the device does not include a microprocessor.
  • sensing electrodes 125 may be electrically connected by wires 126 to the microprocessor 120. Alternatively, the sensing electrodes 125 may be in wireless communication with the microprocessor 120. The sensing electrodes 125 may be selected to sense one or more physiological parameters with reference to a plurality of anatomical target sites, regions or areas. For example, during a treatment regimen for obesity and/or GERD, while applying electrical stimulation to the upper esophageal sphincter (UES) the sensing electrodes 125 may be placed in the esophagus to sense physical parameters such as esophageal peristalsis, pH, pressure, temperature and impedance.
  • UES upper esophageal sphincter
  • the electrical stimulation in the upper esophageal sphincter may be initiated so as to contract the upper esophageal sphincter and impede passage of food from the oropharynx into the esophagus, thereby increasing the time of mastication, reducing the food intake and, preferably, increasing stimulation of the satiety centre.
  • the device 100 does not include sensing electrodes and comprises simply a stimulating arrangement.
  • the stimulator electrodes 105 may be placed by endoscopic, surgical or radiological procedures.
  • the stimulus may be triggered by a transmitter (not shown) external to a patient's body, similar to a remote transmitter for a cardiac pacemaker.
  • the device 100 is designed as a 'micro' device with all the major components— the stimulator electrodes 105, the sensor electrodes 125, the microcontroller 120, the pulse generator 110 and the power source 115 integrated into a single unit, for easy deployment at any desired location in a patient's body.
  • the microdevice contains an outer shell made of a biocompatible, hermetically sealed material such as glass, ceramic, metal, or polymers. For this purpose, any material may be selected that keeps moisture out yet allows radio frequency/electromagnetic or magnetic energy to pass through.
  • the outer shell may also be constructed of an acid corrosion resistant material such as a suitable inert polymer.
  • such materials include: those from the polyolefm family such as HDPE (high density polyethylene), LLDPE (linear low density polyethylene), and UHMWPE (ultra high molecular weight polyethylene); fluoropolymer materials like PTFETM (poly tetrafluoroethylene), FEPTM (fluorinated ethylene propylene) and others; polymethylpentene, and polysulfones; and, some elastomers such as thermoplastic polyurethanes and C-Flex type block copolymers that are stable in acidic environments. Additionally, the outer shell may be constructed of an acid corrosion resistant metal such as platinum, gold, tantalum, titanium, or suitable alloys thereof.
  • an acid corrosion resistant metal such as platinum, gold, tantalum, titanium, or suitable alloys thereof.
  • the microdevice may be coated with an antimicrobial agent such as an antibiotic or antifungal agent to prevent infection at the time of implantation. Additionally, the microdevice may be coated with an immunosuppressent such as a steroid, cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, muromonab CD-3, or antithymocyte globulin to prevent rejection.
  • an antimicrobial agent such as an antibiotic or antifungal agent to prevent infection at the time of implantation.
  • an immunosuppressent such as a steroid, cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, muromonab CD-3, or antithymocyte globulin to prevent rejection.
  • the device 100 has a local energy source 115, such as a battery, that has one or more of the following characteristics: the energy source 115 is rechargeable and has a recharge frequency of once per day for 15 minutes, once per week for approximately 60 minutes, once per month, or once per year; comprises lithium ion battery technology; comprises solid state battery technology; comprises lithium polymer battery technology; comprises super capacitor technology; is not rechargeable; and, is not rechargeable and/or has an implant life of at least one year.
  • a power management unit is used to convert output voltage from the power supply 115 to the specified level of operating voltage of the microprocessor 120 (and its peripherals).
  • the energy source 115 comprises an external power source coupled to the device 100 via a suitable means, such as RF link.
  • the energy source 115 comprises a self-contained power source utilizing any suitable means of generation or storage of energy. Examples of such a power source include a primary battery, a replenishable or rechargeable battery such as a lithium ion battery, an electrolytic capacitor, and a super- or ultra- capacitor, etc.
  • a suitable means of replenishing or recharging the power source may be used, such as an RF link, an optical link, a thermal link, or any other energy-coupling link.
  • the electro-medical device 100 provides enhanced/improved operational life benefits through optimized operational or therapy protocol parameters.
  • the present specification associates the operational or therapy protocol parameters of the device 100 to a plurality of battery or power source parameters, such as battery service life, capacity, or current, in accordance with the following equations:
  • effusE [%] usable efficiency of battery or power source due to end of life efficiency (before battery or power source voltage drops too low), allowable depth-of-discharge, or similar events or combination of events.
  • I B A T [niA] battery or power source current (current at the battery or power source terminals) in milliamps (mA), where:
  • VOH [V] overhead output voltage (on a constant current output system there is usually the internal voltage that is at least 0.5-2V higher than the output voltage to keep the internals operating in the correct range);
  • VBAT [V] battery or power source voltage (average voltage at the battery terminals);
  • PRF [Hz] therapy pulse repetition frequency in hertz (Hz);
  • ISLP [mA] sleep current (power when the device is in an "off state, but is still capable of doing background tests, watchdog, or other basic monitoring);
  • I TM [mA] average telemetry current (can be high depending on telemetry protocol).
  • the microprocessor 120 can be programmed using the Equations A and B such that the device 100 produces electrical pulses of varying shape, duration and frequency so as to produce the desired stimulation or therapeutic effect while enabling optimization and/or improvement of the operational life of the device 100 (or the battery 115).
  • the microprocessor 120 can be programmed to continuously provide a pulse train of 3 mA, 200 ⁇ pulses at a rate of 20 Hz (i.e. no duty cycle) with a minimum operational battery life of 5 years.
  • the operational battery life and therefore of the device can be varied and approximately set to a desired level by varying the operational or therapy protocol parameters.
  • the output of the device 100 can be programmed to vary a plurality of operational or therapy protocol parameters, such as: the number of pulses in a pulse train; the shape of pulses in a pulse train; the interval between pulse train repetitions; the duration of each pulse; the timing and amplitude of pulses in trains; the desired amount of amperage to be provided to an anatomical target site; and, the desired amount of potential to be provided to an anatomical target site, depending upon the load and the current produced.
  • operational or therapy protocol parameters such as: the number of pulses in a pulse train; the shape of pulses in a pulse train; the interval between pulse train repetitions; the duration of each pulse; the timing and amplitude of pulses in trains; the desired amount of amperage to be provided to an anatomical target site; and, the desired amount of potential to be provided to an anatomical target site, depending upon the load and the current produced.
  • the electrical stimulus can be provided continuously or intermittently. For example, one time or more per hour may be suitable in some circumstances.
  • the electrical stimulus in the stimulator electrodes 105 may have any shape necessary to produce the desired result, including a square, rectangular, sinusoidal or saw-tooth shape.
  • the device 100 can be allowed to engage in automated "on/off duty cycles that can range, for example, from 1 millisecond to 24 hours.
  • stimulation is applied for a long enough period to enable recruitment of adequate nerves and/or muscle fibers to achieve a desired pressure, function or effect.
  • the desired "on” period is patient specific and is preferably calculated based on the time required to change a pressure or function of an anatomical target site, such as the LES, from a baseline pressure or function to a desired therapeutic pressure or function plus additional time to maintain the therapeutic pressure (maintenance time) or function.
  • the maintenance time ranges from 1 second to 12 hours.
  • the “off period is preferably set in order to prevent development of tolerance or muscle fatigue, to improve device functionality, and to optimize energy consumption from the energy source/battery.
  • the desired “off period ranges, for example, from 1 second to 24 hours.
  • the desired “off period is patient specific and calculated based on the time required to change a pressure or function of an anatomical target site, such as the LES, from the desired therapeutic pressure or function to a baseline pressure or function plus optional additional time to maintain the baseline pressure (relaxation time) or function.
  • the relaxation time ranges from 1 second to 12 hours.
  • the operational or therapy protocol parameters which are effectuated through an electrical pulse, may comprise any of the variable ranges detailed in the table 200 of Figure 2. Accordingly, the operational life of the battery and therefore of the electro -medical device can be advantageously estimated for further optimization with reference to the therapy protocol parameters.
  • an electro-medical device is implanted in a patient with the goal of providing at least one more year of operational life after having already operated for a predefined amount of time with a predefined set of parameters.
  • Lbat is set to 8,760 hours for the goal of one year and the stimulation parameters, including pulse width, pulse frequency, and pulse amplitude are left unchanged with the intention of only changing the duty cycle (DCth).
  • the equations are then rearranged to solve for DCth. Once DCth is calculated, the electro -medical device can be reprogrammed to adjust the duty cycle to reflect the new value.
  • a maximum power source capacity for the device is set (CAPBAT). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the maximum power source capacity value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 3 is a flow chart illustrating the steps involved in one embodiment of setting a maximum power source capacity and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification.
  • the maximum power source capacity (CAPBAT) for the device is set.
  • one or more of the other parameters effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 308.
  • a desired, minimum, or maximum power source capacity for the device is set (CAPBAT). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum power source capacity value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 4 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum power source capacity and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification.
  • the desired, minimum, or maximum power source capacity (CAPBAT) for the device is set.
  • one or more of the other parameters effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 408.
  • a desired, minimum, or maximum amount of current required to run the device and not including the stimulation current is set (ISOH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, C APBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value.
  • the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 5 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum amount of current required to run the device, and not including the stimulation current, and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification.
  • the desired, minimum, or maximum amount of current required to run the device (ISOH), and not including the stimulation current is set.
  • one or more of the other parameters effra, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 508.
  • a desired, minimum, or maximum useable efficiency of power source is set (effusE). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum useable efficiency of power source value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 6 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum useable efficiency of power source and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification.
  • the desired, minimum, or maximum useable efficiency of power source (effusE) for the device is set.
  • one or more of the other parameters effra, ISOH, CAPBAT, LBAT, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 608.
  • a desired, minimum, or maximum level of current exiting the device from an output terminal is set (ITH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of current exiting the device from an output terminal value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 7 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of current existing the device from an output terminal and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification.
  • the desired, minimum, or maximum level of current exiting the device from an output terminal (ITH) is set.
  • one or more of the other parameters effra, ISOH, CAPBAT, LBAT, effusE, IBAT, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 708.
  • a desired, minimum, or maximum level of voltage at an output terminal of the device is set (VTH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of voltage at an output terminal of the device value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 8 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of voltage at an output terminal of the device and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification.
  • the desired, minimum, or maximum level of voltage at an output terminal of the device (VTH) is set.
  • one or more of the other parameters effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 808.
  • a desired, minimum, or maximum level of an overhead output voltage is set (VOH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of an overhead output voltage value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 9 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of an overhead output voltage and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification.
  • the desired, minimum, or maximum level of an overhead output voltage (VOH) of the device is set.
  • one or more of the other parameters effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VBAT, PRF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 908.
  • a desired, minimum, or maximum level of battery or power source voltage is set (VBAT). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of battery or power source voltage value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 10 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of battery or power source output voltage and optimizing one or more of the other operational parameters of an electromedical device using the equations of the present specification.
  • the desired, minimum, or maximum level of battery or power source output voltage (VBAT) of the device is set.
  • one or more of the other parameters effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, PPVF, PW, DCTH, ISLP, and ITM
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 1008.
  • a desired, minimum, or maximum level of sleep current is set (ISLP).
  • a minority, and preferably only one, of the remaining parameters is subject to optimization or modification, with the remainder being a fixed value.
  • the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 1 1 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of sleep current and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification.
  • the desired, minimum, or maximum level of sleep current (ISLP) of the device is set.
  • one or more of the other parameters effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, and ITM
  • step 1 106 fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 1 108.
  • a desired, minimum, or maximum level of average telemetry current is set (ITM). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, and ISLP) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of average telemetry current value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B.
  • Figure 12 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of average telemetry current and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification.
  • the desired, minimum, or maximum level of average telemetry current (ITM) of the device is set.
  • one or more of the other parameters effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, and ISLP
  • fixed values for the remaining parameters are set.
  • equations A and B of the present specification the one or more other parameters subject to optimization/modification is optimized at step 1208.

Abstract

A device for electrically stimulating one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient. The device has a pulse generator providing electrical stimulation to the anatomical target sites; a power source for powering the pulse generator; stimulator electrodes connected to the pulse generator for stimulating the anatomical target sites; one or more optional sensing electrodes for monitoring physiological parameters with reference to the anatomical target sites; and a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source.

Description

IMPLANTABLE ELECTRO-MEDICAL DEVICE PROGRAMMABLE FOR
IMPROVED OPERATIONAL LIFE
CROSS-REFERENCE
The present application relies on U.S. Patent Provisional No. 62/080,793, filed on November 17, 2014, for priority and is hereby incorporated by reference in its entirety.
FIELD
This invention relates generally to an electro-medical device for electrical stimulation of one or more anatomical target sites to treat a plurality of biological conditions. More particularly, this invention relates to an electro -medical device that is programmable for improved operational life with reference to a plurality of desired treatment stimulations or protocols.
BACKGROUND
Electrical stimulation has been suggested for use in the treatment of biological conditions of patient's, such as, obesity and GERD. The treatment typically involves placing stimulator electrodes, of an electro-medical device, at or near an anatomical site in the patient by endoscopic, surgical or radiological procedures. The operational life of such electro-medical devices is contingent upon the service life of the battery or energy source powering the device. The service life of the energy source is in turn affected by the electrical stimulation regimen and therefore a plurality of parameters governing the regimen.
Therefore, there is a need for an electro-medical device that can be programmed for desired or improved operational life benefits in relation to the electrical stimulation or therapy regimen parameters.
SUMMARY
The following embodiments and aspects thereof are described and illustrated in conjunction with systems, tools and methods, which are meant to be exemplary and illustrative, not limiting in scope. The present specification discloses a device for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said device comprising: a pulse generator providing electrical stimulation to said one or more anatomical target sites, wherein said electrical stimulation comprises a stimulation current; a power source for powering said pulse generator; at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; and, a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
LBAT = CAPBAreffusE , where
!BAT
IBAT [(effTH ■ ITH ■ ■ PRF■ PW) + IS0H]■ DCTH + ISLP ■ (1 - DCTH) + I w herein effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency; wherein PW is a function of a pulse width; wherein DCTH is a function of a duty cycle; wherein ISLP is a function of sleep current; and wherein ITM is a function of average telemetry current.
Optionally, the power source is a battery. The battery may be rechargeable or non- rechargeable. The operational life parameters of the battery may comprise battery capacity, usable efficiency of battery due to end of life efficiency, and battery current.
Optionally, the power source is a capacitor. The therapy protocol parameters, for an electrical stimulation pulse train, may comprise: number of pulses, shape of pulses, interval between pulse train repetitions, duration of a pulse, timing and amplitude of pulses, amperage to be provided to said one or more anatomical target sites, potential to be provided to said one or more anatomical target sites, and duty cycles.
Optionally, the device further comprises at least one sensor for monitoring at least one physiological parameter of said patient. The microprocessor may modify said therapy protocol parameters based upon physiological information sensed by said at least one sensor.
The present specification also discloses a device for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said device comprising: a pulse generator providing electrical stimulation to said one or more anatomical target sites; a power source for powering said pulse generator; at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
CAPBAT-effUSE
LBAT = BA " , where
IBAT — [{effrn■ ITH■ ∑ ∑£iL■ PRF■ PW) + IS0H]■ DCTH + ISLP ■ (1 - DCTH) + I ; and,
VBAT
at least one sensor connected to said microprocessor for sensing at least one physiological parameter of said patient; wherein effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency; wherein PW is a function of a pulse width; wherein DCTH is a function of a duty cycle; wherein ISLP is a function of sleep current; and wherein I™ is a function of average telemetry current.
Optionally, the power source is a battery. The battery may be rechargeable or non- rechargeable. The operational life parameters of the battery may comprise battery capacity, usable efficiency of battery due to end of life efficiency, and battery current.
Optionally, the power source is a capacitor.
The therapy protocol parameters, for an electrical stimulation pulse train, may comprise: number of pulses, shape of pulses, interval between pulse train repetitions, duration of a pulse, timing and amplitude of pulses, amperage to be provided to said one or more anatomical target sites, potential to be provided to said one or more anatomical target sites, and duty cycles.
The present specification also discloses a system for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said system comprising: a pulse generator providing electrical stimulation to said one or more anatomical target sites; a power source for powering said pulse generator; at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; and, a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
IBAT — ■ ITH ■
Figure imgf000005_0001
V™ll°H■ PRF■ PW) + *SOH] ■ DCTH + ISLP " (1 - DCTH) + I wherein effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency; wherein PW is a function of a pulse width; wherein DCTH is a function of a duty cycle; wherein ISLP is a function of sleep current; and wherein ITM is a function of average telemetry current.
Optionally, the power source is a battery. The battery may be rechargeable or non- rechargeable.
Optionally, the power source is a capacitor.
Optionally, the system further comprises at least one sensor for monitoring at least one physiological parameter of said patient. The microprocessor may modify said therapy protocol parameters based upon physiological information sensed by said at least one sensor.
The aforementioned and other embodiments of the present invention shall be described in greater depth in the drawings and detailed description provided below.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other features and advantages of the present invention will be appreciated, as they become better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:
Figure 1 is a block diagram illustration of an electro-medical device in accordance with an embodiment;
Figure 2 shows exemplary therapy protocol parameters;
Figure 3 is a flow chart illustrating the steps involved in one embodiment of setting a maximum power source capacity and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
Figure 4 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum power source capacity and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification;
Figure 5 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum amount of current required to run the device, and not including the stimulation current, and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
Figure 6 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum useable efficiency of power source and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
Figure 7 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of current existing the device from an output terminal and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
Figure 8 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of voltage at an output terminal of the device and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification;
Figure 9 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of an overhead output voltage and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
Figure 10 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of battery or power source output voltage and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification;
Figure 11 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of sleep current and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification; and
Figure 12 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of average telemetry current and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification. DETAILED DESCRIPTION
The present invention is directed towards a plurality of operational or therapy protocol parameters with battery parameters for improved or enhanced operational life of a programmable implantable electro-medical device for the treatment of a plurality of biological conditions. The electro-medical device, including macrostimulators or microstimulators, typically employs stimulator electrodes which can be implanted with minimal invasiveness at or near a treatment or stimulation site.
The electro-medical device can be used to treat a plurality of biological conditions and achieve a plurality of different therapeutic objectives: treatment of GERD (gastroesophageal reflux disease); treatment of diurnal GERD; treatment of nocturnal GERD; reducing the frequency of transient lower esophageal relaxation (tLESR) events; reducing acid exposure during tLESR events; normalizing a patient's LES (lower esophageal sphincter) function; treatment of hypotensive LES; increasing resting or baseline LES pressure; treating a patient to normalize esophageal pH; treating a patient to normalize esophageal pH when in the supine position; treating a patient to prevent damage to the patient's lower esophageal sphincter caused by acid reflux; treatment of supine position induced GERD; treatment of activity-induced GERD; prevention of supine position induced GERD; prevention of activity-induced GERD; treating a patient to mitigate damage to the patient's lower esophageal sphincter caused by acid reflux; treating a patient to stop progression of damage to the patient's lower esophageal sphincter caused by acid reflux; treating a patient to minimize transient relaxations of the patient's lower esophageal sphincter; modifying or increasing LES pressure; modifying or increasing esophageal body pressure; modifying or improving esophageal body function; modifying or improving esophageal sensation induced by the refluxate; modifying or improving the volume of refluxate; modifying or improving the clearance of the refluxate; reducing incidents of heartburn; modifying or improving esophageal acid exposure; increasing lower esophageal tone; detecting when a patient swallows; detecting when a patient is eating; treating a gastrointestinal condition of a patient; treating a patient to minimize the patient's consumption of certain solids or liquids; reducing patient symptoms associated with GERD wherein such reduction is measured by an improvement in a patient quality of life survey and wherein an improvement is calculated by having a patient provide a first set of responses to the quality of life survey prior to treatment and having a patient provide a second set of responses to the quality of life survey after the treatment and comparing the first set of responses to the second set of responses; treating a patient for any of the above-listed therapeutic objectives with the additional requirement of avoiding tissue habituation, tissue fatigue, tissue injury or damage, or certain adverse reactions, including, but not limited to, chest pain, difficulty in swallowing, pain associated with swallowing, heartburn, injury to surrounding tissue, or arrhythmias.
The electro-medical device may be implanted within a plurality of anatomical target sites or regions to achieve one or more of the therapeutic objectives described above. Treatment/target sites, or implantation sites, include: the lower esophageal sphincter; proximate the LES or in the vicinity of the LES, wherein proximate or in the vicinity of the LES is defined as +/- 3 cm from the LES; the esophageal body; the upper esophageal sphincter (UES); within, proximate to, or in the vicinity of the gastro-esophageal junction; the esophagus, including esophageal body, LES, and UES; proximate the esophagus or in the vicinity of the esophagus, wherein proximate or in the vicinity of the esophagus is defined as +/- 3 cm from the esophagus; at or within the stomach; in direct contact with or +/- 3 cm from the gastric wall, including the anterior antrum, posterior antrum, anterior corpus, posterior corpus, lesser curvature, greater curvature, anterior fundus, and posterior fundus; in direct contact with or +/- 3 cm from the nerves supplying the LES or gastroesophageal junction; in direct contact with or +/- 3 cm from the nerves supplying the esophageal body; in direct contact with or +/- 3 cm from the nerves supplying the UES; or in direct contact with or +/- 3 cm from the nerves supplying the esophagus, including the esophageal body, LES, and UES.
The present specification is directed towards multiple embodiments. The following disclosure is provided in order to enable a person having ordinary skill in the art to practice the invention. Language used in this specification should not be interpreted as a general disavowal of any one specific embodiment or used to limit the claims beyond the meaning of the terms used therein. The general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. Also, the terminology and phraseology used is for the purpose of describing exemplary embodiments and should not be considered limiting. Thus, the present invention is to be accorded the widest scope encompassing numerous alternatives, modifications and equivalents consistent with the principles and features disclosed. For purpose of clarity, details relating to technical material that is known in the technical fields related to the invention have not been described in detail so as not to unnecessarily obscure the present invention.
In one embodiment, the electro-medical device may be a conventional pulse generator, a miniature pulse generator, or a microstimulator.
In one embodiment, any electro-medical device, including a macrostimulator or microstimulator, can be programmed to achieve improved or enhanced operational life of the device while implementing a plurality of desired operational or therapy protocols. It should be appreciated that the relationship / association of operational or therapy protocol parameters with battery parameters, in accordance with an aspect of the present invention, are implemented in an electro-medical device, such as a macrostimulator or microstimulator, having a plurality of electrodes, or at least one electrode, including, but not limited to, unipolar or bipolar electrodes, an energy source, such as a battery, and a microprocessor which stores a plurality of programmatic instructions wherein the instructions, when executed by the device, execute the stimulation therapies while achieving optimized and/or improved operational life of the device.
It should be appreciated that the relationships/associations of operational or therapy protocol parameters with battery parameters described herein, for desired or improved operational life of the battery or electro-medical device, can be used with a plurality of different electro- medical devices, including those electrical stimulation devices disclosed in U.S. patent application Ser. Nos. 13/975,162, 13/661,483, 13/041,063, 13/041,114, 13/447,168, 12/359,317, and 13/463,803, U.S. patent Nos. 6,901,295, 6,591,137, 6,774,153, 6,826,428, 7,738,961, 8,447,403, 8,447,404, 8,538,534, and 8,160,709, and PCT Application Numbers PCT/US11/27243 and PCTUS 13/56520, all of which are herein incorporated by reference.
Figure 1 shows an embodiment of an electro-medical device 100 wherein a plurality of stimulator electrodes 105 is provided for placement at or near a treatment or stimulation site. A pulse generator 110 is provided for stimulation of the stimulator electrodes 105 and corresponding portion of the treatment or stimulation site. The pulse generator 110 is connected to a power source 115 for supplying a source of power. The pulse generator 110 is further connected to the stimulator electrodes 105 by wires 106 for applying electrical stimulus to the electrodes 105. Alternatively, the stimulator electrodes 105 may be coupled to the pulse generator 110 in a wireless fashion using an RF link, an ultrasonic link, a thermal link, a magnetic link, an electromagnetic link or an optical link.
The power source 115 can be either a direct current source or an alternating current source. The number of stimulator electrodes 105 is determined by a number of factors, including the size of the electrodes, their power and the size of the desired placement area.
In one embodiment, the pulse generator 110 is controlled by a microprocessor 120 for applying the electrical stimulus for periods of variable duration and variable power/frequency, so as to produce a plurality of treatment stimulations/therapies. In another embodiment, the device does not include a microprocessor.
Additionally or optionally sensing electrodes 125 may be electrically connected by wires 126 to the microprocessor 120. Alternatively, the sensing electrodes 125 may be in wireless communication with the microprocessor 120. The sensing electrodes 125 may be selected to sense one or more physiological parameters with reference to a plurality of anatomical target sites, regions or areas. For example, during a treatment regimen for obesity and/or GERD, while applying electrical stimulation to the upper esophageal sphincter (UES) the sensing electrodes 125 may be placed in the esophagus to sense physical parameters such as esophageal peristalsis, pH, pressure, temperature and impedance. Upon sensing appropriate changes in esophageal peristalsis, pH, pressure, temperature and/or impedance, the electrical stimulation in the upper esophageal sphincter may be initiated so as to contract the upper esophageal sphincter and impede passage of food from the oropharynx into the esophagus, thereby increasing the time of mastication, reducing the food intake and, preferably, increasing stimulation of the satiety centre. In one embodiment, the device 100 does not include sensing electrodes and comprises simply a stimulating arrangement.
The stimulator electrodes 105 may be placed by endoscopic, surgical or radiological procedures.
The stimulus may be triggered by a transmitter (not shown) external to a patient's body, similar to a remote transmitter for a cardiac pacemaker.
In one embodiment, the device 100 is designed as a 'micro' device with all the major components— the stimulator electrodes 105, the sensor electrodes 125, the microcontroller 120, the pulse generator 110 and the power source 115 integrated into a single unit, for easy deployment at any desired location in a patient's body. The microdevice contains an outer shell made of a biocompatible, hermetically sealed material such as glass, ceramic, metal, or polymers. For this purpose, any material may be selected that keeps moisture out yet allows radio frequency/electromagnetic or magnetic energy to pass through. The outer shell may also be constructed of an acid corrosion resistant material such as a suitable inert polymer. Examples of such materials include: those from the polyolefm family such as HDPE (high density polyethylene), LLDPE (linear low density polyethylene), and UHMWPE (ultra high molecular weight polyethylene); fluoropolymer materials like PTFETM (poly tetrafluoroethylene), FEPTM (fluorinated ethylene propylene) and others; polymethylpentene, and polysulfones; and, some elastomers such as thermoplastic polyurethanes and C-Flex type block copolymers that are stable in acidic environments. Additionally, the outer shell may be constructed of an acid corrosion resistant metal such as platinum, gold, tantalum, titanium, or suitable alloys thereof.
The microdevice may be coated with an antimicrobial agent such as an antibiotic or antifungal agent to prevent infection at the time of implantation. Additionally, the microdevice may be coated with an immunosuppressent such as a steroid, cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, muromonab CD-3, or antithymocyte globulin to prevent rejection.
In one embodiment, the device 100 has a local energy source 115, such as a battery, that has one or more of the following characteristics: the energy source 115 is rechargeable and has a recharge frequency of once per day for 15 minutes, once per week for approximately 60 minutes, once per month, or once per year; comprises lithium ion battery technology; comprises solid state battery technology; comprises lithium polymer battery technology; comprises super capacitor technology; is not rechargeable; and, is not rechargeable and/or has an implant life of at least one year. In one embodiment, a power management unit is used to convert output voltage from the power supply 115 to the specified level of operating voltage of the microprocessor 120 (and its peripherals).
In one embodiment, the energy source 115 comprises an external power source coupled to the device 100 via a suitable means, such as RF link. In another embodiment, the energy source 115 comprises a self-contained power source utilizing any suitable means of generation or storage of energy. Examples of such a power source include a primary battery, a replenishable or rechargeable battery such as a lithium ion battery, an electrolytic capacitor, and a super- or ultra- capacitor, etc. In case the self-contained energy source is replenishable or rechargeable, any suitable means of replenishing or recharging the power source may be used, such as an RF link, an optical link, a thermal link, or any other energy-coupling link.
In accordance with an aspect of the present specification, the electro-medical device 100 provides enhanced/improved operational life benefits through optimized operational or therapy protocol parameters. To enable improved or desired operational life benefits of the device 100, the present specification associates the operational or therapy protocol parameters of the device 100 to a plurality of battery or power source parameters, such as battery service life, capacity, or current, in accordance with the following equations:
CAPBAreffusE — Equation A
!BAT Where:
LBAT [Hr] = battery or power source service life in hours (Hr)
• CAPBAT [mAHr] = battery or power source capacity in milliamps hours (mAHr)
effusE [%] = usable efficiency of battery or power source due to end of life efficiency (before battery or power source voltage drops too low), allowable depth-of-discharge, or similar events or combination of events.
IBAT [niA] = battery or power source current (current at the battery or power source terminals) in milliamps (mA), where:
IBAT — [{effTH ■ ITH ■ ■ PRF■ PW) + IS0H] ■ DCTH + ISLP ■ (1 - DCTH) + I — Equation B
Where:
• effra [%]= a general efficiency term for therapy, i.e. (output stimulation circuit
current)/(input stimulation circuit current) x 100%;
• ITH [mA] = therapy current (current exiting the electro-medical device output terminal); • VTH [V] = therapy voltage (voltage at the electro-medical device output terminal);
• VOH [V] = overhead output voltage (on a constant current output system there is usually the internal voltage that is at least 0.5-2V higher than the output voltage to keep the internals operating in the correct range);
• VBAT [V] = battery or power source voltage (average voltage at the battery terminals);
• PRF [Hz] = therapy pulse repetition frequency in hertz (Hz);
• PW [s] = therapy pulse width in second(s);
• ISOH [mA] = stimulation overhead current (there is often a non-scalable power loss
associated with the output driver circuitry, thus not part of effra), i.e. the amount of current dedicated to run the stimulation circuity and which does not include the actual stimulation current itself;
• DCTH [%] = therapy duty cycle (average operation time);
• ISLP [mA] = sleep current (power when the device is in an "off state, but is still capable of doing background tests, watchdog, or other basic monitoring); and
• ITM [mA] = average telemetry current (can be high depending on telemetry protocol).
A therapy which requires a lower amount of energy increases service life of the battery 115 and therefore the long-term functionality of the electro-medical device 100. Accordingly, the microprocessor 120 can be programmed using the Equations A and B such that the device 100 produces electrical pulses of varying shape, duration and frequency so as to produce the desired stimulation or therapeutic effect while enabling optimization and/or improvement of the operational life of the device 100 (or the battery 115). In one embodiment, for example, using Equations A and B, the microprocessor 120 can be programmed to continuously provide a pulse train of 3 mA, 200 μβεΰ pulses at a rate of 20 Hz (i.e. no duty cycle) with a minimum operational battery life of 5 years. Thus, as would be appreciated by persons of ordinary skill in the art, the operational battery life and therefore of the device can be varied and approximately set to a desired level by varying the operational or therapy protocol parameters.
The output of the device 100, as controlled by the microcontroller 120, can be programmed to vary a plurality of operational or therapy protocol parameters, such as: the number of pulses in a pulse train; the shape of pulses in a pulse train; the interval between pulse train repetitions; the duration of each pulse; the timing and amplitude of pulses in trains; the desired amount of amperage to be provided to an anatomical target site; and, the desired amount of potential to be provided to an anatomical target site, depending upon the load and the current produced.
In addition, the electrical stimulus can be provided continuously or intermittently. For example, one time or more per hour may be suitable in some circumstances.
In various embodiments, the electrical stimulus in the stimulator electrodes 105 may have any shape necessary to produce the desired result, including a square, rectangular, sinusoidal or saw-tooth shape.
In one embodiment, the device 100 can be allowed to engage in automated "on/off duty cycles that can range, for example, from 1 millisecond to 24 hours. During the "on" period, stimulation is applied for a long enough period to enable recruitment of adequate nerves and/or muscle fibers to achieve a desired pressure, function or effect. The desired "on" period is patient specific and is preferably calculated based on the time required to change a pressure or function of an anatomical target site, such as the LES, from a baseline pressure or function to a desired therapeutic pressure or function plus additional time to maintain the therapeutic pressure (maintenance time) or function. For example, the maintenance time ranges from 1 second to 12 hours. The "off period is preferably set in order to prevent development of tolerance or muscle fatigue, to improve device functionality, and to optimize energy consumption from the energy source/battery. The desired "off period ranges, for example, from 1 second to 24 hours. The desired "off period is patient specific and calculated based on the time required to change a pressure or function of an anatomical target site, such as the LES, from the desired therapeutic pressure or function to a baseline pressure or function plus optional additional time to maintain the baseline pressure (relaxation time) or function. For example, the relaxation time ranges from 1 second to 12 hours.
As an example, the operational or therapy protocol parameters, which are effectuated through an electrical pulse, may comprise any of the variable ranges detailed in the table 200 of Figure 2. Accordingly, the operational life of the battery and therefore of the electro -medical device can be advantageously estimated for further optimization with reference to the therapy protocol parameters. For example, in one embodiment, an electro-medical device is implanted in a patient with the goal of providing at least one more year of operational life after having already operated for a predefined amount of time with a predefined set of parameters. In this example, using the equations above, Lbat is set to 8,760 hours for the goal of one year and the stimulation parameters, including pulse width, pulse frequency, and pulse amplitude are left unchanged with the intention of only changing the duty cycle (DCth). The equations are then rearranged to solve for DCth. Once DCth is calculated, the electro -medical device can be reprogrammed to adjust the duty cycle to reflect the new value.
In one embodiment, a maximum power source capacity for the device is set (CAPBAT). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the maximum power source capacity value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 3 is a flow chart illustrating the steps involved in one embodiment of setting a maximum power source capacity and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification. At step 302, the maximum power source capacity (CAPBAT) for the device is set. At step 304, one or more of the other parameters (effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is determined to be subject to optimization/modification. Then, at step 306, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 308.
In one embodiment, a desired, minimum, or maximum power source capacity for the device is set (CAPBAT). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum power source capacity value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 4 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum power source capacity and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification. At step 402, the desired, minimum, or maximum power source capacity (CAPBAT) for the device is set. At step 404, one or more of the other parameters (effra, ISOH, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is determined to be subject to optimization/modification. Then, at step 406, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 408.
In one embodiment, a desired, minimum, or maximum amount of current required to run the device and not including the stimulation current is set (ISOH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, C APBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum amount of current required to run the device, and not including the stimulation current, value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 5 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum amount of current required to run the device, and not including the stimulation current, and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification. At step 502, the desired, minimum, or maximum amount of current required to run the device (ISOH), and not including the stimulation current, is set. At step 504, one or more of the other parameters (effra, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is determined to be subject to optimization/modification. Then, at step 506, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 508.
In one embodiment, a desired, minimum, or maximum useable efficiency of power source is set (effusE). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum useable efficiency of power source value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 6 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum useable efficiency of power source and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification. At step 602, the desired, minimum, or maximum useable efficiency of power source (effusE) for the device is set. At step 604, one or more of the other parameters (effra, ISOH, CAPBAT, LBAT, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is determined to be subject to optimization/modification. Then, at step 606, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 608.
In one embodiment, a desired, minimum, or maximum level of current exiting the device from an output terminal is set (ITH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of current exiting the device from an output terminal value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 7 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of current existing the device from an output terminal and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification. At step 702, the desired, minimum, or maximum level of current exiting the device from an output terminal (ITH) is set. At step 704, one or more of the other parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, VTH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is determined to be subject to optimization/modification. Then, at step 706, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 708.
In one embodiment, a desired, minimum, or maximum level of voltage at an output terminal of the device is set (VTH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of voltage at an output terminal of the device value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 8 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of voltage at an output terminal of the device and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification. At step 802, the desired, minimum, or maximum level of voltage at an output terminal of the device (VTH) is set. At step 804, one or more of the other parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VOH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is determined to be subject to optimization/modification. Then, at step 806, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 808.
In one embodiment, a desired, minimum, or maximum level of an overhead output voltage is set (VOH). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of an overhead output voltage value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 9 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of an overhead output voltage and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification. At step 902, the desired, minimum, or maximum level of an overhead output voltage (VOH) of the device is set. At step 904, one or more of the other parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VBAT, PRF, PW, DCTH, ISLP, and ITM) is determined to be subject to optimization/modification. Then, at step 906, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 908.
In one embodiment, a desired, minimum, or maximum level of battery or power source voltage is set (VBAT). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, PRF, PW, DCTH, ISLP, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of battery or power source voltage value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 10 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of battery or power source output voltage and optimizing one or more of the other operational parameters of an electromedical device using the equations of the present specification. At step 1002, the desired, minimum, or maximum level of battery or power source output voltage (VBAT) of the device is set. At step 1004, one or more of the other parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, PPVF, PW, DCTH, ISLP, and I™) is determined to be subject to optimization/modification. Then, at step 1006, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 1008.
In one embodiment, a desired, minimum, or maximum level of sleep current is set (ISLP).
Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, and ITM) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of sleep current value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 1 1 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of sleep current and optimizing one or more of the other operational parameters of an electro -medical device using the equations of the present specification. At step 1 102, the desired, minimum, or maximum level of sleep current (ISLP) of the device is set. At step 1 104, one or more of the other parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, and ITM) is determined to be subject to optimization/modification. Then, at step 1 106, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 1 108.
In one embodiment, a desired, minimum, or maximum level of average telemetry current is set (ITM). Additionally, a minority, and preferably only one, of the remaining parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, and ISLP) is subject to optimization or modification, with the remainder being a fixed value. Using the desired, minimum, or maximum level of average telemetry current value and the other fixed values, the minority, or preferably one, of the parameters subject to optimization of modification is then determined using Equations A and B. Figure 12 is a flow chart illustrating the steps involved in one embodiment of setting a desired, minimum, or maximum level of average telemetry current and optimizing one or more of the other operational parameters of an electro-medical device using the equations of the present specification. At step 1202, the desired, minimum, or maximum level of average telemetry current (I™) of the device is set. At step 1204, one or more of the other parameters (effra, ISOH, CAPBAT, LBAT, effusE, IBAT, ITH, VTH, VOH, VBAT, PRF, PW, DCTH, and ISLP) is determined to be subject to optimization/modification. Then, at step 1206, fixed values for the remaining parameters are set. Using equations A and B of the present specification, the one or more other parameters subject to optimization/modification is optimized at step 1208.
The above examples are merely illustrative of the many applications of the system of present invention. Although only a few embodiments of the present invention have been described herein, it should be understood that the present invention might be embodied in many other specific forms without departing from the spirit or scope of the invention. Therefore, the present examples and embodiments are to be considered as illustrative and not restrictive, and the invention may be modified within the scope of the appended claims.

Claims

CLAIMS We claim:
1. A device for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said device comprising:
a pulse generator providing electrical stimulation to said one or more anatomical target sites, wherein said electrical stimulation comprises a stimulation current;
a power source for powering said pulse generator;
at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; and,
a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
IBAT — [{effjH ■ ITH ■ ■ PRF ■ PW) + IS0H] ■ DCTH + ISLP ■ (1 - DCTH) + I wherein effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency; wherein PW is a function of a pulse width; wherein DCTH is a function of a duty cycle; wherein ISLP is a function of sleep current; and wherein ITM is a function of average telemetry current.
2. The device of claim 1, wherein said power source is a battery.
3. The device of claim 2, wherein said battery is rechargeable.
4. The device of claim 2, wherein said battery is non-rechargeable.
5. The device of claim 2, wherein the operational life parameters of the battery comprise battery capacity, usable efficiency of battery due to end of life efficiency, and battery current.
6. The device of claim 1, wherein said power source is a capacitor.
7. The device of claim 1, wherein said therapy protocol parameters, for an electrical stimulation pulse train, comprise: number of pulses, shape of pulses, interval between pulse train repetitions, duration of a pulse, timing and amplitude of pulses, amperage to be provided to said one or more anatomical target sites, potential to be provided to said one or more anatomical target sites, and duty cycles.
8. The device of claim 1, further comprising at least one sensor for monitoring at least one physiological parameter of said patient.
9. The device of claim 8, wherein said microprocessor modifies said therapy protocol parameters based upon physiological information sensed by said at least one sensor.
10. A device for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said device comprising:
a pulse generator providing electrical stimulation to said one or more anatomical target sites;
a power source for powering said pulse generator;
at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites;
a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
CAPBAT-effUSE
-BAT = ; , wnere
'BAT
IBAT — [{effTH ■ ITH ■ lf^ L■ PRF■ PW) + *SOH] ■ DCTH + ISLP ■ (1 - DCTH) + L ; and, at least one sensor connected to said microprocessor for sensing at least one physiological parameter of said patient;
wherein effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency; wherein PW is a function of a pulse width; wherein DCTH is a function of a duty cycle; wherein ISLP is a function of sleep current; and wherein I™ is a function of average telemetry current.
1 1. The device of claim 10, wherein said power source is a battery.
12. The device of claim 1 1 , wherein said battery is rechargeable.
13. The device of claim 1 1 , wherein said battery is non-rechargeable.
14. The device of claim 1 1 , wherein the operational life parameters of the battery comprise battery capacity, usable efficiency of battery due to end of life efficiency, and battery current.
15. The device of claim 10, wherein said power source is a capacitor.
16. The device of claim 10, wherein said therapy protocol parameters, for an electrical stimulation pulse train, comprise: number of pulses, shape of pulses, interval between pulse train repetitions, duration of a pulse, timing and amplitude of pulses, amperage to be provided to said one or more anatomical target sites, potential to be provided to said one or more anatomical target sites, and duty cycles.
17. A system for electrical stimulation of one or more anatomical target sites in a patient and for use in the treatment of a plurality of biological conditions of the patient, said system comprising:
a pulse generator providing electrical stimulation to said one or more anatomical target sites;
a power source for powering said pulse generator; at least one stimulator electrode connected to said pulse generator for stimulating said one or more anatomical target sites; and,
a microprocessor programmed to vary a plurality of therapy protocol parameters governing the electrical stimulation to thereby modify operational life parameters of the power source, wherein the therapy protocol parameters and the operational life of the power source are associated according to the following relations:
IBAT — [{effjH ■ ITH ■ ■ PRF ■ PW) + IS0H] ■ DCTH + ISLP ■ (1 - DCTH) + I wherein effm is a function of an output stimulation circuit current divided by an input stimulation circuit current; wherein ISOH is equal to an amount of current required to run the device and not including the stimulation current; wherein LBAT is a function of power source service life; wherein CAPBAT is a function of power source capacity; wherein effusE is a function of a usable efficiency of power source; wherein IBAT is a function of power source current; wherein ITH is a function of a level of current exiting the device from an output terminal; wherein VTH is a function of a level of voltage at an output terminal of the device; wherein VOH is a function of an overhead output voltage; wherein VBAT is a function of a power source voltage; wherein PRF is a function of a pulse repetition frequency; wherein PW is a function of a pulse width; wherein DCTH is a function of a duty cycle; wherein ISLP is a function of sleep current; and wherein ITM is a function of average telemetry current.
18. The system of claim 17, wherein said power source is a battery.
19. The system of claim 18, wherein said battery is rechargeable.
20. The system of claim 18, wherein said battery is non-rechargeable.
21. The device of claim 17, wherein said power source is a capacitor.
22. The system of claim 17, further comprising at least one sensor for monitoring at least one physiological parameter of said patient.
23. The system of claim 22, wherein said microprocessor modifies said therapy protocol parameters based upon physiological information sensed by said at least one sensor.
PCT/US2015/061108 2014-11-17 2015-11-17 Implantable electro-medical device programmable for improved operational life WO2016081468A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP15861744.9A EP3220999A2 (en) 2014-11-17 2015-11-17 Implantable electro-medical device programmable for improved operational life

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462080793P 2014-11-17 2014-11-17
US62/080,793 2014-11-17

Publications (2)

Publication Number Publication Date
WO2016081468A2 true WO2016081468A2 (en) 2016-05-26
WO2016081468A3 WO2016081468A3 (en) 2016-06-30

Family

ID=55960783

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/061108 WO2016081468A2 (en) 2014-11-17 2015-11-17 Implantable electro-medical device programmable for improved operational life

Country Status (3)

Country Link
US (2) US9682234B2 (en)
EP (1) EP3220999A2 (en)
WO (1) WO2016081468A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925375B2 (en) 2014-12-09 2018-03-27 Mordechay Esh Non-invasive device and method for treating gastro esophageal reflux disease (GERD) and the digestive system
CN109683094A (en) * 2018-12-19 2019-04-26 武汉新能源研究院有限公司 A kind of quick method for separating and its sorting unit of lithium ion battery

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10603489B2 (en) 2008-10-09 2020-03-31 Virender K. Sharma Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
WO2010042686A1 (en) 2008-10-09 2010-04-15 Sharma Virender K Method and apparatus for stimulating the vascular system

Family Cites Families (253)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3909883A (en) 1972-02-28 1975-10-07 Richco Plastic Co Locking base for plastic components
US3910281A (en) 1973-10-09 1975-10-07 Bio Medicus Inc Suture anchor
US4393883A (en) 1980-11-03 1983-07-19 Medtronic, Inc. Single pass A-V lead
US4612934A (en) 1981-06-30 1986-09-23 Borkan William N Non-invasive multiprogrammable tissue stimulator
US4414986A (en) 1982-01-29 1983-11-15 Medtronic, Inc. Biomedical stimulation lead
US4735205A (en) 1986-02-24 1988-04-05 Medtronic, Inc. Method and apparatus including a sliding insulation lead for cardiac assistance
US5451204A (en) 1988-07-22 1995-09-19 Yoon; Inbae Multifunctional devices for endoscopic surgical procedures
US5697375A (en) 1989-09-18 1997-12-16 The Research Foundation Of State University Of New York Method and apparatus utilizing heart sounds for determining pressures associated with the left atrium
US5197491A (en) 1990-09-28 1993-03-30 Brunswick Biomedical Technologies, Inc. Esophageal-stomach displacement electrode
US5117827A (en) 1990-10-26 1992-06-02 Sandhill Scientific, Inc. Apparatus and method for ambulatory reflux monitoring
US5263480A (en) 1991-02-01 1993-11-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5188104A (en) 1991-02-01 1993-02-23 Cyberonics, Inc. Treatment of eating disorders by nerve stimulation
US5231988A (en) 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5193539A (en) 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Implantable microstimulator
US5707362A (en) 1992-04-15 1998-01-13 Yoon; Inbae Penetrating instrument having an expandable anchoring portion for triggering protrusion of a safety member and/or retraction of a penetrating member
US5810810A (en) 1992-04-23 1998-09-22 Scimed Life Systems, Inc. Apparatus and method for sealing vascular punctures
IT1260485B (en) 1992-05-29 1996-04-09 PROCEDURE AND DEVICE FOR THE TREATMENT OF THE OBESITY OF A PATIENT
US5292344A (en) 1992-07-10 1994-03-08 Douglas Donald D Percutaneously placed electrical gastrointestinal pacemaker stimulatory system, sensing system, and pH monitoring system, with optional delivery port
US5360428A (en) 1992-07-22 1994-11-01 Hutchinson Jr William B Laparoscopic instrument with electrical cutting wires
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US5782749A (en) 1994-05-10 1998-07-21 Riza; Erol D. Laparoscopic surgical instrument with adjustable grip
US6405732B1 (en) 1994-06-24 2002-06-18 Curon Medical, Inc. Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors
US6056744A (en) 1994-06-24 2000-05-02 Conway Stuart Medical, Inc. Sphincter treatment apparatus
US6006755A (en) 1994-06-24 1999-12-28 Edwards; Stuart D. Method to detect and treat aberrant myoelectric activity
US5531778A (en) 1994-09-20 1996-07-02 Cyberonics, Inc. Circumneural electrode assembly
US5606242A (en) 1994-10-04 1997-02-25 Duracell, Inc. Smart battery algorithm for reporting battery parameters to an external device
US5633573A (en) * 1994-11-10 1997-05-27 Duracell, Inc. Battery pack having a processor controlled battery operating system
US5556425A (en) 1994-11-28 1996-09-17 Brunswick Biomedical Technologies, Inc. Esophageal/stomach placement electrode
BR9606241A (en) 1995-03-16 1997-09-23 Milliken Res Corp Apparatus and process for selective cutting of textile fabric and a textile fabric
US5540730A (en) 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US5709224A (en) 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
US8092224B2 (en) 1995-11-22 2012-01-10 James A. Jorasch Systems and methods for improved health care compliance
US5716392A (en) 1996-01-05 1998-02-10 Medtronic, Inc. Minimally invasive medical electrical lead
WO1997029802A2 (en) 1996-02-20 1997-08-21 Advanced Bionics Corporation Improved implantable microstimulator and systems employing the same
US5690691A (en) 1996-05-08 1997-11-25 The Center For Innovative Technology Gastro-intestinal pacemaker having phased multi-point stimulation
CA2264831C (en) 1996-09-05 2003-08-12 The Governors Of The University Of Alberta Gastro-intestinal electrical pacemaker
US6464697B1 (en) 1998-02-19 2002-10-15 Curon Medical, Inc. Stomach and adjoining tissue regions in the esophagus
US5716385A (en) 1996-11-12 1998-02-10 University Of Virginia Crural diaphragm pacemaker and method for treating esophageal reflux disease
US6026326A (en) 1997-01-13 2000-02-15 Medtronic, Inc. Apparatus and method for treating chronic constipation
US7114502B2 (en) 1997-02-26 2006-10-03 Alfred E. Mann Foundation For Scientific Research Battery-powered patient implantable device
US5893883A (en) 1997-04-30 1999-04-13 Medtronic, Inc. Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user
US5861014A (en) 1997-04-30 1999-01-19 Medtronic, Inc. Method and apparatus for sensing a stimulating gastrointestinal tract on-demand
US5836994A (en) 1997-04-30 1998-11-17 Medtronic, Inc. Method and apparatus for electrical stimulation of the gastrointestinal tract
US6216039B1 (en) 1997-05-02 2001-04-10 Medtronic Inc. Method and apparatus for treating irregular gastric rhythms
US6321124B1 (en) 1997-05-28 2001-11-20 Transneuronix, Inc. Implant device for electrostimulation and/or monitoring of endo-abdominal cavity tissue
IT1292016B1 (en) 1997-05-28 1999-01-25 Valerio Cigaina IMPLANT DEVICE PARTICULARLY FOR ELECTROSTIMULATION AND / OR ELECTRO-REGISTRATION OF ENDOABDOMINAL VISCERS
US6381495B1 (en) 1997-05-28 2002-04-30 Transneuronix, Inc. Medical device for use in laparoscopic surgery
EP0996482B1 (en) 1997-07-16 2007-02-14 Metacure NV Smooth muscle controller
US7006871B1 (en) 1997-07-16 2006-02-28 Metacure N.V. Blood glucose level control
US6091992A (en) 1997-12-15 2000-07-18 Medtronic, Inc. Method and apparatus for electrical stimulation of the gastrointestinal tract
US6104955A (en) 1997-12-15 2000-08-15 Medtronic, Inc. Method and apparatus for electrical stimulation of the gastrointestinal tract
JP3497722B2 (en) 1998-02-27 2004-02-16 富士通株式会社 Semiconductor device, method of manufacturing the same, and transfer tray thereof
CA2320109A1 (en) 1998-03-06 1999-09-10 Curon Medical, Inc. Apparatus to electrosurgically treat esophageal sphincters
US6740082B2 (en) 1998-12-29 2004-05-25 John H. Shadduck Surgical instruments for treating gastro-esophageal reflux
US6477424B1 (en) 1998-06-19 2002-11-05 Medtronic, Inc. Medical management system integrated programming apparatus for communication with an implantable medical device
US7599736B2 (en) 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US6360130B1 (en) 1998-09-30 2002-03-19 Medtronic, Inc. Temporary bi-polar heart wire
US6221039B1 (en) 1998-10-26 2001-04-24 Scimed Life Systems, Inc. Multi-function surgical instrument
US20050137644A1 (en) 1998-10-26 2005-06-23 Boveja Birinder R. Method and system for vagal blocking and/or vagal stimulation to provide therapy for obesity and other gastrointestinal disorders
US6366814B1 (en) 1998-10-26 2002-04-02 Birinder R. Boveja External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
US6611715B1 (en) 1998-10-26 2003-08-26 Birinder R. Boveja Apparatus and method for neuromodulation therapy for obesity and compulsive eating disorders using an implantable lead-receiver and an external stimulator
US7076307B2 (en) 2002-05-09 2006-07-11 Boveja Birinder R Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders
US6097984A (en) 1998-11-25 2000-08-01 Medtronic, Inc. System and method of stimulation for treating gastro-esophageal reflux disease
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US6285897B1 (en) 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
US6684104B2 (en) 1999-04-14 2004-01-27 Transneuronix, Inc. Gastric stimulator apparatus and method for installing
US6895278B1 (en) 1999-04-14 2005-05-17 Transneuronix, Inc. Gastric stimulator apparatus and method for use
US6542776B1 (en) 1999-04-14 2003-04-01 Transneuronix Inc. Gastric stimulator apparatus and method for installing
US6587719B1 (en) 1999-07-01 2003-07-01 Cyberonics, Inc. Treatment of obesity by bilateral vagus nerve stimulation
US6820019B1 (en) 1999-07-31 2004-11-16 Medtronic, Inc. Device and method for determining and communicating the remaining life of a battery in an implantable neurological tissue stimulating device
US6510332B1 (en) 1999-08-30 2003-01-21 Transneuronix, Inc. Electrode leads for use in laparoscopic surgery
US20070203531A9 (en) 1999-12-03 2007-08-30 Medtronic, Inc. Heart rate variability control of gastric electrical stimulator
US6853862B1 (en) 1999-12-03 2005-02-08 Medtronic, Inc. Gastroelectric stimulation for influencing pancreatic secretions
US6564105B2 (en) 2000-01-21 2003-05-13 Medtronic Minimed, Inc. Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
US6600953B2 (en) 2000-12-11 2003-07-29 Impulse Dynamics N.V. Acute and chronic electrical signal therapy for obesity
US6612983B1 (en) 2000-03-28 2003-09-02 Medtronic, Inc. Pancreatic secretion response to stimulation test protocol
US8761903B2 (en) 2000-10-11 2014-06-24 The Board Of Regents Of The University Of Texas Gastrointestinal electrical stimulation
WO2001076690A1 (en) 2000-04-11 2001-10-18 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
US8467874B2 (en) 2000-04-11 2013-06-18 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
US6826428B1 (en) 2000-04-11 2004-11-30 The Board Of Regents Of The University Of Texas System Gastrointestinal electrical stimulation
US7054689B1 (en) 2000-08-18 2006-05-30 Advanced Bionics Corporation Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction
JP2004509714A (en) 2000-09-26 2004-04-02 トランスニューロニックス　インコーポレイテッド Method and apparatus for treating obesity by electrical stimulation of the gastrointestinal tract utilizing detected activity
US7039470B1 (en) 2000-09-26 2006-05-02 Micronet Medical, Inc. Medical lead and method for medical lead manufacture
US20020077675A1 (en) 2000-09-26 2002-06-20 Transneuronix, Inc. Minimally invasive surgery placement of stimulation leads in mediastinal structures
US6591137B1 (en) 2000-11-09 2003-07-08 Neuropace, Inc. Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders
US20060206160A1 (en) 2000-11-15 2006-09-14 Transneuronix, Inc. Process and electrostimulation device for treating obesity and/or gastroesophageal reflux disease
US6615084B1 (en) 2000-11-15 2003-09-02 Transneuronix, Inc. Process for electrostimulation treatment of morbid obesity
US6832114B1 (en) 2000-11-21 2004-12-14 Advanced Bionics Corporation Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes
US6879861B2 (en) 2000-12-21 2005-04-12 Medtronic, Inc. Polymeric materials with improved dielectric breakdown strength
US6609025B2 (en) 2001-01-02 2003-08-19 Cyberonics, Inc. Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation
CN100366310C (en) 2001-01-05 2008-02-06 超治疗股份有限公司 Regulation of eating habits
US6754536B2 (en) 2001-01-31 2004-06-22 Medtronic, Inc Implantable medical device affixed internally within the gastrointestinal tract
US6876885B2 (en) 2001-01-31 2005-04-05 Medtronic, Inc. Implantable bifurcated gastrointestinal lead with active fixation
US6952613B2 (en) 2001-01-31 2005-10-04 Medtronic, Inc. Implantable gastrointestinal lead with active fixation
US6535764B2 (en) 2001-05-01 2003-03-18 Intrapace, Inc. Gastric treatment and diagnosis device and method
US9668690B1 (en) 2001-05-01 2017-06-06 Intrapace, Inc. Submucosal gastric implant device and method
US7702394B2 (en) 2001-05-01 2010-04-20 Intrapace, Inc. Responsive gastric stimulator
US6678561B2 (en) 2001-05-23 2004-01-13 Surgical Development Ag Heartburn and reflux disease treatment apparatus
SE0102313D0 (en) 2001-06-28 2001-06-28 Obtech Medical Ag Intestine dysfunction treatment apparatus
US6901295B2 (en) 2001-07-14 2005-05-31 Virender K. Sharma Method and apparatus for electrical stimulation of the lower esophageal sphincter
US20070162085A1 (en) 2001-07-23 2007-07-12 Dilorenzo Biomedical, Llc Method, apparatus, surgical technique, and stimulation parameters for autonomic neuromodulation for the treatment of obesity
US20060167498A1 (en) 2001-07-23 2006-07-27 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of disease
US20060116736A1 (en) 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US6760626B1 (en) 2001-08-29 2004-07-06 Birinder R. Boveja Apparatus and method for treatment of neurological and neuropsychiatric disorders using programmerless implantable pulse generator system
US7734355B2 (en) 2001-08-31 2010-06-08 Bio Control Medical (B.C.M.) Ltd. Treatment of disorders by unidirectional nerve stimulation
US20060155261A1 (en) 2001-09-19 2006-07-13 Curon Medical, Inc. Systems and methods for treating tissue regions of the body
WO2003026736A2 (en) 2001-09-28 2003-04-03 Northstar Neuroscience, Inc. Methods and implantable apparatus for electrical therapy
US20050137480A1 (en) 2001-10-01 2005-06-23 Eckhard Alt Remote control of implantable device through medical implant communication service band
US6745079B2 (en) 2001-11-07 2004-06-01 Medtronic, Inc. Electrical tissue stimulation apparatus and method
DE10155087B4 (en) 2001-11-09 2005-12-22 Pulsion Medical Systems Ag Implantable muscle stimulation device and associated computer program
US20040073453A1 (en) 2002-01-10 2004-04-15 Nenov Valeriy I. Method and system for dispensing communication devices to provide access to patient-related information
US20080147137A1 (en) 2002-01-23 2008-06-19 Biocontrol Medical Ltd. Inhibition of sympathetic nerves
US20030144708A1 (en) 2002-01-29 2003-07-31 Starkebaum Warren L. Methods and apparatus for retarding stomach emptying for treatment of eating disorders
US7463934B2 (en) 2002-04-12 2008-12-09 Medtronic, Inc. Implantable medical device with captivation fixation
US20040015201A1 (en) 2002-04-22 2004-01-22 Transneuronix, Inc. Process for electrostimulation treatment of obesity
US20040193229A1 (en) 2002-05-17 2004-09-30 Medtronic, Inc. Gastric electrical stimulation for treatment of gastro-esophageal reflux disease
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
WO2004011085A1 (en) 2002-07-26 2004-02-05 Transneuronix, Inc. Improved process for electrostimulation treatment of morbid obesity
WO2004016315A1 (en) 2002-08-19 2004-02-26 Arizona Board Regents Neurostimulator
US20040088033A1 (en) 2002-10-31 2004-05-06 Smits Karel F.A.A. Implantable medical lead designs
US20040138586A1 (en) 2002-11-20 2004-07-15 Ganz Robert A. Apparatus and method for determining yield pressure
US7069083B2 (en) 2002-12-13 2006-06-27 Advanced Neuromodulation Systems, Inc. System and method for electrical stimulation of the intervertebral disc
JP2004201901A (en) 2002-12-25 2004-07-22 Yoshimi Kurokawa Stomach electrostimulator
US7167750B2 (en) 2003-02-03 2007-01-23 Enteromedics, Inc. Obesity treatment with electrically induced vagal down regulation
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US7203551B2 (en) 2003-04-25 2007-04-10 Medtronic, Inc. Implantable lead-based sensor powered by piezoelectric transformer
US7742818B2 (en) 2003-05-19 2010-06-22 Medtronic, Inc. Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof
US7620454B2 (en) 2003-05-19 2009-11-17 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US8282561B2 (en) 2003-05-23 2012-10-09 Arizona Board Of Regents Piezo micro-markers for ultrasound medical diagnostics
US7263405B2 (en) 2003-08-27 2007-08-28 Neuro And Cardiac Technologies Llc System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities
JP4161854B2 (en) 2003-09-02 2008-10-08 ソニー株式会社 Battery remaining capacity calculation method, battery remaining capacity calculation device, and battery remaining capacity calculation program
US20050070974A1 (en) 2003-09-29 2005-03-31 Knudson Mark B. Obesity and eating disorder stimulation treatment with neural block
US7200443B2 (en) 2003-10-07 2007-04-03 John Faul Transcutaneous electrical nerve stimulator for appetite control
US7054690B2 (en) 2003-10-22 2006-05-30 Intrapace, Inc. Gastrointestinal stimulation device
WO2005051486A1 (en) 2003-11-28 2005-06-09 University Technologies International Inc. Method and apparatus for gastrointestinal motility control
US20050149142A1 (en) 2004-01-07 2005-07-07 Starkebaum Warren L. Gastric stimulation responsive to sensing feedback
US7177693B2 (en) 2004-01-07 2007-02-13 Medtronic, Inc. Gastric stimulation for altered perception to treat obesity
US20050209653A1 (en) 2004-03-16 2005-09-22 Medtronic, Inc. Intra-luminal device for gastrointestinal electrical stimulation
US20050222637A1 (en) 2004-03-30 2005-10-06 Transneuronix, Inc. Tachygastrial electrical stimulation
US20050222638A1 (en) 2004-03-30 2005-10-06 Steve Foley Sensor based gastrointestinal electrical stimulation for the treatment of obesity or motility disorders
US8135473B2 (en) 2004-04-14 2012-03-13 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
EP1763816A4 (en) 2004-04-22 2009-08-12 Smiths Detection Inc Autonomous monitoring method and system using sensors of different sensitivities
US20050245788A1 (en) 2004-04-28 2005-11-03 Medtronic, Inc. Esophageal delivery system and method with position indexing
US7127295B2 (en) 2004-05-05 2006-10-24 Evans John R Device and method for placement of electrodes in the GI tract
US8790275B2 (en) 2004-05-17 2014-07-29 Given Imaging (Los Angeles) Llc Analysis and visualization methods using manometry data
WO2005113061A1 (en) 2004-05-19 2005-12-01 The Board Of Trustees, The Leland Stanford Junior University Devices and methods for treating cardiac pathologies
US7087053B2 (en) 2004-05-27 2006-08-08 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter with bifurcated, collapsible tip for sensing and ablating
WO2005123185A1 (en) 2004-06-10 2005-12-29 Ndi Medical, Llc Implantable system for processing myoelectric signals
US20070060979A1 (en) 2004-06-10 2007-03-15 Ndi Medical, Llc Implantable pulse generator systems and methods for providing functional and / or therapeutic stimulation of muscles and / or nerves and / or central nervous system tissue
US9205255B2 (en) 2004-06-10 2015-12-08 Medtronic Urinary Solutions, Inc. Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20070066995A1 (en) 2004-06-10 2007-03-22 Ndi Medical, Llc Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20070067000A1 (en) 2004-06-10 2007-03-22 Ndi Medical, Llc Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20070060955A1 (en) 2004-06-10 2007-03-15 Ndi Medical, Llc Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US8165692B2 (en) * 2004-06-10 2012-04-24 Medtronic Urinary Solutions, Inc. Implantable pulse generator power management
US7664551B2 (en) 2004-07-07 2010-02-16 Medtronic Transneuronix, Inc. Treatment of the autonomic nervous system
US8452407B2 (en) 2004-08-16 2013-05-28 Boston Scientific Neuromodulation Corporation Methods for treating gastrointestinal disorders
US7519433B2 (en) 2004-08-25 2009-04-14 Medtronic Transneuronix, Inc. Gastrointestinal stimulation lead
US7914468B2 (en) 2004-09-22 2011-03-29 Svip 4 Llc Systems and methods for monitoring and modifying behavior
US20070244375A1 (en) 2004-09-30 2007-10-18 Transeuronix, Inc. Method for Screening and Treating Patients at Risk of Medical Disorders
US7593777B2 (en) 2004-10-26 2009-09-22 Medtronic, Inc. Fixation of a medical implant to the exterior of a body organ
US20060095077A1 (en) 2004-10-29 2006-05-04 Tronnes Carole A Expandable fixation structures
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US7871415B2 (en) 2005-03-11 2011-01-18 The Johns Hopkins University Devices and methods for treatment of gastrointestinal disorders
WO2006129321A2 (en) 2005-06-02 2006-12-07 Metacure N.V. Gi lead implantation
US7519431B2 (en) 2005-04-11 2009-04-14 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US20060247717A1 (en) 2005-04-28 2006-11-02 Medtronic, Inc. Electrical stimulation of the gastrointestinal tract to regulate motility
US7406351B2 (en) 2005-04-28 2008-07-29 Medtronic, Inc. Activity sensing for stimulator control
US20060247718A1 (en) 2005-04-28 2006-11-02 Medtronic, Inc. Dual mode electrical stimulation to treat obesity
US7899540B2 (en) 2005-04-29 2011-03-01 Cyberonics, Inc. Noninvasively adjustable gastric band
US7310557B2 (en) 2005-04-29 2007-12-18 Maschino Steven E Identification of electrodes for nerve stimulation in the treatment of eating disorders
US7835796B2 (en) 2005-04-29 2010-11-16 Cyberonics, Inc. Weight loss method and device
US20070016274A1 (en) 2005-06-29 2007-01-18 Boveja Birinder R Gastrointestinal (GI) ablation for GI tumors or to provide therapy for obesity, motility disorders, G.E.R.D., or to induce weight loss
US9050005B2 (en) 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
US9011328B2 (en) 2005-10-18 2015-04-21 Pneumoflex Systems, Llc Oral-esophageal-gastric device with esophageal cuff to reduce gastric reflux and/or emesis
US20070100388A1 (en) 2005-10-31 2007-05-03 Medtronic, Inc. Implantable medical device providing adaptive neurostimulation therapy for incontinence
US20070106338A1 (en) 2005-11-10 2007-05-10 Electrocore, Inc. Direct and Indirect Control of Muscle for the Treatment of Pathologies
US20070106337A1 (en) 2005-11-10 2007-05-10 Electrocore, Inc. Methods And Apparatus For Treating Disorders Through Neurological And/Or Muscular Intervention
US20070142699A1 (en) 2005-12-16 2007-06-21 Acoustx Corporation Methods and implantable apparatuses for treating an esophageal disorder such as gastroesophageal reflux disease
US20070142884A1 (en) 2005-12-16 2007-06-21 Acoustx Corporation Methods and apparatuses for treating an esophageal disorder such as gastroesophageal reflux disease
US7660636B2 (en) 2006-01-04 2010-02-09 Accelerated Care Plus Corp. Electrical stimulation device and method for the treatment of dysphagia
US7769455B2 (en) * 2006-01-27 2010-08-03 Cyberonics, Inc. Power supply monitoring for an implantable device
US7653437B2 (en) 2006-01-31 2010-01-26 Medtronic, Inc. Method and apparatus for determining optimal pacing therapy timing intervals
US7848802B2 (en) 2006-02-24 2010-12-07 Medtronic, Inc. Programming interface with a concentric axial view of a stimulation lead with complex electrode array geometry
US8380321B2 (en) 2006-02-24 2013-02-19 Medtronic, Inc. Programming interface with a cross-sectional view of a stimulation lead with complex electrode array geometry
US7937161B2 (en) 2006-03-31 2011-05-03 Boston Scientific Scimed, Inc. Cardiac stimulation electrodes, delivery devices, and implantation configurations
US20070238942A1 (en) 2006-04-10 2007-10-11 Esophamet Corp. Apparatus and method for detecting gastroesophageal reflux disease (gerd)
US20070255352A1 (en) 2006-04-27 2007-11-01 Roline Glen M Implantable sensors having current-based switches for improved fault tolerance
US8155758B2 (en) 2006-04-27 2012-04-10 Medtronic, Inc. Fault tolerant implantable pulse generators and implantable cardioverter-defibrillators incorporating physiologic sensors and methods for implementing fault tolerance in same
US20070265668A1 (en) 2006-04-27 2007-11-15 Reinke James D Fault tolerant sensors and methods for implementing fault tolerance in implantable medical devices
US20070265662A1 (en) 2006-04-27 2007-11-15 Ufford Keith A Implantable electromagnetic interference tolerant, wired sensors and methods for implementing same
US20070265674A1 (en) 2006-04-27 2007-11-15 Olson John C Fault tolerant implantable sensors having redundant electrical grounding connections
US20070265671A1 (en) 2006-04-27 2007-11-15 Roberts Jonathan P Selectable switching of implantable sensors to provide fault toleance for implantable medical devices
US20070265666A1 (en) 2006-04-27 2007-11-15 Roberts Jonathan P Implantable sensors having high impedance couplings providing current pathways for improved fault tolerance
US20070282410A1 (en) 2006-04-28 2007-12-06 Cross Thomas E Jr Implantable medical lead assemblies with improved flexibility and extensibility and having a substantially two-dimensional nature
US7558629B2 (en) 2006-04-28 2009-07-07 Medtronic, Inc. Energy balance therapy for obesity management
US20070255335A1 (en) 2006-04-28 2007-11-01 Medtronic, Inc. Controller for gastric constriction device with selectable electrode configurations
US20070255336A1 (en) 2006-04-28 2007-11-01 Medtronic, Inc. Gastric constriction device with selectable electrode combinations
WO2007136712A2 (en) 2006-05-17 2007-11-29 Medtronic, Inc. Electrical stimulation therapy to promote gastric distention for obesity management
WO2007137026A2 (en) 2006-05-18 2007-11-29 Cedars-Sinai Medical Center Electrical stimulation of the lower esophageal sphincter
US9020597B2 (en) 2008-11-12 2015-04-28 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US8135478B2 (en) 2006-07-13 2012-03-13 Rainbow Medical Ltd Peltier unidirectional and selective nerve stimulation
US8892217B2 (en) 2006-08-03 2014-11-18 Medtronic, Inc. Implantable medical lead with proximal retrieval wire
WO2008017080A2 (en) 2006-08-03 2008-02-07 Hansen Medical, Inc. Systems for performing minimally invasive procedures
US20080039904A1 (en) 2006-08-08 2008-02-14 Cherik Bulkes Intravascular implant system
EP2068719B1 (en) 2006-09-15 2017-10-25 Boston Scientific Scimed, Inc. System for anchoring stomach implant
US9724510B2 (en) 2006-10-09 2017-08-08 Endostim, Inc. System and methods for electrical stimulation of biological systems
US7738961B2 (en) 2006-10-09 2010-06-15 Endostim, Inc. Method and apparatus for treatment of the gastrointestinal tract
US20140222106A1 (en) 2006-10-09 2014-08-07 Endostim, Inc. Device and Implantation System for Electrical Stimulation of Biological Systems
US9345879B2 (en) 2006-10-09 2016-05-24 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
AU2007313319B2 (en) 2006-10-13 2012-03-22 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8055343B2 (en) * 2006-10-20 2011-11-08 Cardiac Pacemakers, Inc. Dynamic battery management in an implantable device
US7711437B1 (en) 2006-11-22 2010-05-04 Pacesetter, Inc. Lead fixation device
US20100076345A1 (en) 2006-12-01 2010-03-25 Soffer Edy E Method, device and system for automatic detection of eating and drinking
US7794425B2 (en) 2006-12-21 2010-09-14 Kimberly-Clark Worldwide, Inc. Gastro-esophageal reflux control system and pump
CA2714754A1 (en) 2007-02-13 2008-08-21 Virender K. Sharma Method and apparatus for electrical stimulation of the pancreatico-biliary system
EP2117639B1 (en) 2007-02-21 2013-05-22 St. Jude Medical AB Detect eating to initiate gastric pacing
JP5074803B2 (en) 2007-03-30 2012-11-14 ニプロ株式会社 Echo-contrastable metal needle
US7962214B2 (en) 2007-04-26 2011-06-14 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
WO2008134059A1 (en) 2007-04-30 2008-11-06 Medtronic, Inc. Shifting of electrical stimulation electrode combinations among differently sized electrode arrays
WO2008134052A1 (en) 2007-04-30 2008-11-06 Medtronic, Inc. Parameter-directed shifting of electrical stimulation electrode combinations
EP2152149A4 (en) 2007-05-04 2013-05-15 Univ Arizona Systems and methods for wireless transmission of biopotentials
WO2008153834A1 (en) 2007-05-31 2008-12-18 Beth Israel Deaconess Medical Center Low profile suture needle holder
US8066689B2 (en) 2007-07-11 2011-11-29 Apollo Endosurgery, Inc. Methods and systems for submucosal implantation of a device for diagnosis and treatment with a therapeutic agent
US8080138B2 (en) 2007-07-16 2011-12-20 Arrowhead Center, Inc. Desalination using low-grade thermal energy
US8214049B2 (en) 2007-07-25 2012-07-03 Intrapace Inc. Gastric stimulation systems and methods utilizing a transgastric probe
US8235985B2 (en) 2007-08-31 2012-08-07 Voyage Medical, Inc. Visualization and ablation system variations
US8301265B2 (en) 2007-09-10 2012-10-30 Medtronic, Inc. Selective depth electrode deployment for electrical stimulation
US7983755B2 (en) 2007-10-01 2011-07-19 Medtronic, Inc. Gastric electrical stimulation with multi-site stimulation anti-desensitization feature
WO2009094609A1 (en) 2008-01-25 2009-07-30 Sharma Virender K Device and implantation system for electrical stimulation of biological systems
WO2009114008A1 (en) 2008-03-11 2009-09-17 Sharma Virender K Method and apparatus for treatment of the gastrointestinal tract
EP2330979A4 (en) 2008-09-02 2013-10-09 Univ Arizona Apparatus, system, and method for ultrasound powered neurotelemetry
US8409200B2 (en) 2008-09-03 2013-04-02 Ethicon Endo-Surgery, Inc. Surgical grasping device
WO2010135634A2 (en) 2009-05-22 2010-11-25 Arizona Board Of Regents For And On Behalf Of Arizona State University Systems, and methods for neurostimulation and neurotelemetry using semiconductor diode systems
EP2408517A1 (en) 2009-03-03 2012-01-25 Medtronic, Inc Electrical stimulation therapy to promote gastric distention for obesity management
US9155885B2 (en) 2009-04-24 2015-10-13 Medtronic, Inc. Incontinence therapy
US20120259389A1 (en) 2009-09-21 2012-10-11 Warren Starkebaum Treatment of postprandial hyperglycemia by gastric electrical stimulation
EP2480283A1 (en) 2009-09-21 2012-08-01 Medtronic, Inc. Waveforms for electrical stimulation therapy
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US8447403B2 (en) 2010-03-05 2013-05-21 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
CN103079633B (en) 2010-03-11 2016-05-04 梅恩斯塔伊医疗公司 Be used for the treatment of modular stimulator, implanted RF ablation system and the using method of backache
US8888699B2 (en) 2010-04-29 2014-11-18 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
US20140135886A1 (en) 2010-12-14 2014-05-15 United States Government Department Of Veterans Affairs Devices, systems and methods for the treatment of medical disorders
CN103596515A (en) 2011-04-14 2014-02-19 恩多斯提姆公司 Systems and methods for treating gastroesophageal reflux disease
US20120277619A1 (en) 2011-04-29 2012-11-01 Medtronic, Inc. Detecting food intake based on impedance
EP2704791B1 (en) 2011-05-03 2016-07-13 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
WO2013033673A1 (en) 2011-09-02 2013-03-07 Endostim, Inc. Endoscopic lead implantation method
US8706234B2 (en) 2012-02-21 2014-04-22 Virender K. Sharma System and method for electrical stimulation of anorectal structures to treat anal dysfunction
CN104394930B (en) 2012-03-09 2016-11-09 安特罗麦迪克斯公司 The safety feature being used in Medical Devices
US9623238B2 (en) 2012-08-23 2017-04-18 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US9498619B2 (en) 2013-02-26 2016-11-22 Endostim, Inc. Implantable electrical stimulation leads
CN105848708A (en) 2013-09-03 2016-08-10 恩多斯蒂姆股份有限公司 Methods and systems of electrode polarity switching in electrical stimulation therapy
EP3071291A4 (en) 2013-11-20 2017-08-02 Endostim, Inc. Systems and methods for electrical stimulation of biological systems
CN105939755A (en) 2013-11-20 2016-09-14 恩多斯蒂姆股份有限公司 Lead implantation method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925375B2 (en) 2014-12-09 2018-03-27 Mordechay Esh Non-invasive device and method for treating gastro esophageal reflux disease (GERD) and the digestive system
US10661081B2 (en) 2014-12-09 2020-05-26 Gerdcare Medical Ltd. Non-invasive device and method for treating gastro esophageal reflux disease (GERD) and the digestive system
CN109683094A (en) * 2018-12-19 2019-04-26 武汉新能源研究院有限公司 A kind of quick method for separating and its sorting unit of lithium ion battery

Also Published As

Publication number Publication date
US9682234B2 (en) 2017-06-20
WO2016081468A3 (en) 2016-06-30
US20180001087A1 (en) 2018-01-04
US20160136419A1 (en) 2016-05-19
EP3220999A2 (en) 2017-09-27

Similar Documents

Publication Publication Date Title
US11179568B2 (en) Controlling charge flow in the electrical stimulation of tissue
US20200338339A1 (en) Apparatus, system, and method for selective stimulation
JP6181307B2 (en) A system that provides modulation therapy without perception
US8175717B2 (en) Ultracapacitor powered implantable pulse generator with dedicated power supply
US7904175B2 (en) Trans-esophageal vagus nerve stimulation
US7200504B1 (en) Measuring temperature change in an electronic biomedical implant
US7962214B2 (en) Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US7869884B2 (en) Non-surgical device and methods for trans-esophageal vagus nerve stimulation
CN108697886B (en) Method and system for frequency adjustment to optimize charging of an implantable neurostimulator
US11819683B2 (en) Modular stimulation system for the treatment of gastrointestinal disorders
WO2016126807A1 (en) Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US20180001087A1 (en) Implantable Electro-Medical Device Programmable for Improved Operational Life
EP3041564A2 (en) Methods and systems of electrode polarity switching in electrical stimulation therapy
CN104736197A (en) Device and implantation system for electrical stimulation of biological systems
WO2006078958A2 (en) Energy efficient therapeutic pulse generator system
CA2685028A1 (en) Non-surgical device and methods for trans-esophageal vagus nerve stimulation
Becerra Fajardo Microcontrolled injectable stimulators based on electronic rectification of high frequency current bursts

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15861744

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2015861744

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15861744

Country of ref document: EP

Kind code of ref document: A2